TIMOTHY GLERUM: Open Payments
NPI 1255708921 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 34 payments from 8 companies in 2025. Trend: 2023 $543 · 2024 $465 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $341 |
| Madrigal Pharmaceuticals | 5 | $228 |
| Ipsen Biopharmaceuticals, Inc | 2 | $126 |
| Novo Nordisk Inc | 1 | $121 |
| Boston Scientific Corporation | 1 | $113 |
| ABBVIE INC. | 2 | $67 |
| Ardelyx, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: XIFAXAN, REZDIFFRA, IQIRVO, Wegovy, EXALT Model D, RINVOQ, IBSRELA, VOQUEZNA.
Industry payments across MI — which companies pay providers there.
